This table can give you a high-level look at these medications but is not an exhaustive list of all medication information side effects, or warnings
Table of Contents What Is Retatrutide and Its Current Development Status in the UK Risks of Sourcing Unregulated Peptides Online MHRA Guidance on Unlicensed Weight Loss Treatments Approved Alternatives Available Through NHS and Private Clinics How to Speak to a UK Doctor About Emerging Weight Loss Options Scientific References Frequently Asked Questions What Is Retatrutide and Its Current Development Status in the UK Retatrutide is an investigational triple incretin receptor agonist (GLP-1, GIP, and glucagon) developed by Eli Lilly that remains in Phase 3 trials and holds no MHRA marketing authorisation as of mid-2025
We also emphasize a comprehensive approach to weight management , combining medication with nutrition, exercise, and behavioral support to maximize long-term success
Complimentary B12 Injections To boost energy and support weight loss efforts, you will also receive complimentary B12 injections throughout the course
Social and cultural effects Changing attitudes to weight: Reduced obesity prevalence may lessen stigma but could introduce new pressures
When using a new Wegovy pen for the first time, carry out a flow check to make sure it is working correctly
